Article
Recurrent mutations drive rapid HIV escape from two broadly neutralizing antibodies in vivo.
Proceedings of the National Academy of Sciences of the United States of America - 21 Apr 2026
Romero Elena V, Clyde Abigail E, Giorgi Elena E, Westfall Dylan H, Azam Walker, Taylor Megan L, Caskey Marina, Feder Alison F, Cohn Lillian B
Abstract excerpt
Broadly neutralizing antibodies (bNAbs) show promise for HIV treatment and prevention, but are vulnerable to resistance evolution. Comprehensively understanding in vivo viral escape from individual bNAbs is necessary to design bNAb combinations that will provide durable responses. We characterize viral escape from two such bNAbs, 10-1074 and 3BNC117, using deep, longitudinal sequencing of full-length HIV envelope...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
